Fulgent Genetics Inc.

NASDAQ: FLGT · Real-Time Price · USD
21.52
-0.05 (-0.23%)
At close: Aug 20, 2025, 9:43 AM

Fulgent Genetics Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
81.8M 73.46M 76.21M 71.74M 71.03M 64.48M 70.5M 84.69M 67.85M 66.17M 67.7M 105.66M 125.34M 320.27M 251.67M 227.87M 153.62M 359.43M
Cost of Revenue
47.37M 45.12M 44.37M 44.97M 46.53M 44.37M 47.23M 44.84M 47.28M 47.36M 54.72M 59.56M 60.06M 77.72M 62.13M 43.47M 35.86M 74.08M
Gross Profit
34.44M 28.35M 31.85M 26.77M 24.5M 20.11M 23.27M 39.84M 20.57M 18.81M 12.99M 46.09M 65.28M 242.54M 189.54M 184.4M 117.76M 285.35M
Operating Income
-19.71M -19.8M -16.14M -17.08M -18.91M -21.8M -151.12M 214K -19.8M -24.82M -36.58M 352K 12.79M 201.93M 150.86M 159.27M 98.9M 266.92M
Interest Income
8.09M 8.02M 8.29M 8.09M 7.69M 7.63M 5.92M 6.47M 5.1M 3.77M 5.3M 1.41M 958K 45K 100K 496K 604K 282K
Pretax Income
-21.52M -11.72M -8.04M -18.53M -11.21M -14.17M -145.2M 6.86M -14.7M -21.05M -33.46M 1.76M 13.75M 201.98M 150.82M 159.77M 99.5M 267.2M
Net Income
-18.96M -11.53M -5.89M -14.65M -8.71M -13.46M -128.15M -13.11M -11.23M -15.34M -23.83M 1.72M 11.54M 153.98M 104.34M 122.52M 79.81M 200.69M
Selling & General & Admin
38.68M 33.76M 33.88M 30.07M 29.92M 30.48M 42.21M 27.66M 28.72M 31.89M 39.05M 36.13M 41.11M 33.72M 30.3M 18.31M 13.55M 13.01M
Research & Development
13.48M 12.39M 12.11M 11.78M 13.49M 11.43M 11.95M 10.01M 9.69M 9.78M 8.51M 7.51M 6.91M 5.99M 7.46M 6.02M 5.31M 5.42M
Other Expenses
1.99M n/a 1.99M 1.99M n/a n/a -5.89M 1.96M 1.96M 1.97M 2.01M 2.01M 4.47M 906K 911K 797K n/a n/a
Operating Expenses
54.15M 46.15M 47.98M 43.85M 43.41M 41.91M 54.16M 39.63M 40.37M 43.63M 49.56M 45.64M 49.59M 40.61M 38.68M 25.13M 18.86M 18.43M
Interest Expense
17K 14K 210K 14K n/a 8K n/a 70K n/a n/a 234K n/a n/a 45K 35K 496K n/a n/a
Selling & Marketing Expenses
12.29M 8.46M 9.54M 9.12M 8.6M 8.99M 10.5M 10.16M 10.72M 10.08M 10.25M 9.86M 10.87M 7.94M 8.2M 6.01M 5.22M 5.01M
Cost & Expenses
101.52M 93.26M 92.35M 88.82M 89.93M 86.28M 99.43M 84.47M 87.65M 90.99M 104.28M 105.2M 109.65M 118.33M 100.81M 68.59M 54.72M 92.51M
Income Tax Expense
-2.26M 176K -1.85M -3.84M -2.12M -327K -10.86M 20.33M -3.11M -5.2M -9.39M 414K 2.65M 48.42M 47.15M 37.55M 23.59M 66.51M
Shares Outstanding (Basic)
30.83M 30.83M 30.65M 30.42M 30.1M 29.77M 29.77M 30.01M 29.81M 29.54M 29.63M 30.17M 30.36M 30.23M 29.96M 29.67M 29.15M 28.83M
Shares Outstanding (Diluted)
30.83M 30.83M 30.65M 30.42M 30.1M 29.77M 29.77M 30.01M 29.81M 29.54M 30.96M 30.87M 31.19M 31.24M 31.2M 31.17M 30.83M 30.77M
EPS (Basic)
-0.61 -0.37 -0.19 -0.48 -0.29 -0.45 -4.3 -0.44 -0.38 -0.52 -0.8 0.06 0.38 5.09 3.48 4.13 2.74 6.96
EPS (Diluted)
-0.61 -0.37 -0.19 -0.48 -0.29 -0.45 -4.3 -0.44 -0.38 -0.52 -0.8 0.06 0.37 4.93 3.34 3.93 2.59 6.52
EBITDA
-15.45M -5.79M -9.94M -12.6M -12.75M -15.13M -24.35M 12.02M -13.49M -17.95M -26.78M 13.36M 24.04M 201.93M 154.79M 162.45M 101.32M 268.84M
EBIT
-21.5M -11.74M -16.14M -18.52M -18.91M -21.8M -30.89M 6.91M -19.8M -24.82M -36.58M 457K 15.69M 202.03M 150.82M 159.27M 99.5M 267.2M
Depreciation & Amortization
6.05M 5.92M 6.19M 5.92M 6.15M 6.66M 6.53M 6.42M 6.31M 6.88M 9.8M 11.42M 8.35M 5.17M 3.96M 3.17M 2.42M 1.92M